Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold (...)
Alkem Laboratories shares fell 5% after Q4FY25 results showed a modest 4.2% profit rise to Rs 306 crore and margin contraction to 12.4%. While Jefferies downgraded the target to Rs 4,460 citing weak margins, Nomura maintained a ‘Buy’ with a Rs 5,430 target. The company expects high single-digit (...)
Site référencé: The Economic Times
The Economic Times
Stanley Fischer, ex-vice Chair of US Federal Reserve and macroeconomist, dies at 81
1er/06/2025
Rate cut expected, RBI's views in focus with economy near a sizzle
1er/06/2025
Aegis Vopak Terminals, The Leela IPOs to list on Monday : Here’s what GMP indicates
1er/06/2025
Sector-wise ownership : IT sector tops promoter ownership in Nifty50
1er/06/2025
India Inc. ownership tracker : Key trends in NSE-listed companies
1er/06/2025
How to calculate sales to total assets ratio
1er/06/2025
